Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China · Delayed Price · Currency is CNY 13.48
-1.06 (-7.29%)
Aug 20, 2026, 3:04 PM CST
SHE:301211 Market Cap
SHE:301211 has a market cap or net worth of 5.63 billion as of August 20, 2026. Its market cap has increased by 3.97% in one year.
Market Cap
5.63B
Enterprise Value
4.09B
Revenue
459.02M
Ranking
n/a
PE Ratio
168.50
Stock Price
13.48
ChartMarket Cap Chart
Since December 22, 2021, SHE:301211's market cap has decreased from 8.96B to 5.63B, a decrease of -37.15%. That is a compound annual growth rate of -9.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 5.63B | 10.31% |
| Dec 31, 2025 | 5.10B | -16.66% |
| Dec 31, 2024 | 6.12B | -2.25% |
| Dec 29, 2023 | 6.26B | -24.68% |
| Dec 30, 2022 | 8.32B | -7.87% |
| Dec 31, 2021 | 9.03B | 0.78% |
| Dec 22, 2021 | 8.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding